Korean J Dermatol.  2007 Dec;45(12):1233-1239.

The Efficacy and Safety of a Combination Cytopurine/Pentadecanoic Glyceride Topical Solution on Androgenetic Alopecia: A Randomized Double-Blind Placebo-Controlled Clinical Trial

Affiliations
  • 1Department of Dermatology, College of Medicine, Chung-Ang University, Seoul, Korea. drseo@hanafos.com
  • 2CJ LION Corp. Best Living Institute, Seoul, Korea.
  • 3Vision Dermatology Clinic, Seoul, Korea.

Abstract

BACKGROUND: Androgenetic alopecia (AGA) is the most common type of hair loss found in both males and females. Oral finasteride and topical minoxidil are the only drugs approved, till now, by the Food and Drug Administration of USA for the treatment of this condition. Unfortunately, these treatment options are not satisfactory. Therefore, it has been necessary to develop new agents for this psychologically frustrating disease.
OBJECTIVE
This is a 16-week, double-blinded, placebo-controlled, randomized clinical trial to determine whether a new topical agent, cytopurine/pentadecanoic glyceride topical solution, is effective in showing clinical improvements in patients with AGA.
METHODS
A total of 74 men and 21 women (24~55 years old) with AGA were treated either with the new topical solution or a placebo, twice daily. Efficacy was evaluated by daily shed hair count, phototrichogram and patients' subjective and investigators' subjective assessments for clinical improvement. All adverse effects were reported during the study.
RESULTS
After 16 weeks of therapy, combination cytopurine/pentadecanoic glyceride topical solution treatment resulted in a significant improvement from the baseline in total hair count and daily shed hair count. But there were no statistically significant differences in anagen hair count, mean hair diameter, patients' subjective and investigators' subjective assessments for clinical improvement and side effects between the cytopurine/pentadecanoic glyceride treated and placebo group.
CONCLUSION
We have confirmed the efficacy of combination cytopurine/pentadecanoic glyceride topical solution in treating AGA, by an objective assessment with phototrichogram.

Keyword

Androgenetic alopecia; Cytopurine/pentadecanoic glyceride; Hair growth

MeSH Terms

Alopecia*
Female
Finasteride
Hair
Humans
Male
Minoxidil
United States Food and Drug Administration
Finasteride
Minoxidil
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr